Frequent accesses to totally implanted vascular ports in pediatric oncology patients are associated with higher infection rates

Journal of Vascular Access

Volumn 12, Issue 3, 2011, Pages 207-210

  Gapany, Christophe ^a,b   Tercier, Stéphane ^b   Diezi, Manuel ^b   Clement, Chantal ^b   Lemay, Katy ^b   Joseph, Jean Marc ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Complications; Infection; Pediatric oncology; Vascular ports

Indexed keywords

ARTICLE; BACTEREMIA; BLOOD CULTURE; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; INFECTION RATE; INFECTION RISK; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; TOTALLY IMPLANTED VASCULAR PORT; VASCULAR ACCESS DEVICE;

EID: 80053030791     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/JVA.2011.6258     Document Type: Article

References (16)

1. Munro FD, Gillett PM, Wratten JC, et al. Total ly implantable central venous access devices for paediatric oncology patients. Med Pediatr Oncol 1999; 33: 377-81.
2. Bow EJ, Kilpatrick MG, Clinch JJ. Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: a randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life. JCO 1999; 17: 1267.
3. Chang L, Tsai JS, Huang SJ, Shih CC. Evaluation of infectious complications of the implantable venous access system in a general oncologic population. Am J Infect Control 2003; 31: 34-9.
4. Koolen DA, van Laarhoven HW, Wobbes T, Punt CJ. Single-centre experience with tunnelled central venous catheters in 150 cancer patients. Netherland Journal of Medicine 2002: 60; 397-401.
5. Labourey JL, Lacroix P, Genet D, et al. Thrombotic complications of implanted central venous access devices: prospective evaluation. Bull Cancer 2004; 91: 431-6.
6. Freytes CO. Thromboembolic complications related to indwelling central venous catheters in children. Curr Opin Oncol 2003; 15: 289-92.
7. Barnes C, Newall F, Monagle P. Thromboembolic complications related to indwelling central venous catheters in children with oncological/haematological diseases: a retrospective study of 362 catheters. Support Care Cancer 2002; 10: 256-7.
8. Laurenzi L, Natoli S, Benedetti C, et al. Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices. Support Care Cancer 2004; 12: 805-9.
9. Carlo JT, Lamont JP, McCarty TM, Livingston S, Kuhn JA. A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports. Am J Surg 2004; 188: 722-7.
10. 37th Annual Conference of the International Society of Paediatric Oncology, STOP 2005, Vancouver, Canada, 21-24 September 2005. Abstracts. Pediatr Blood Cancer 2005; 45: 365-588.
11. Tercier S, Gapany C, Diezi M, Clement C, Lemay K, Joseph JM. Incidents and complications of totally implanted vascular access devices in children: a prospective study. Patient Sat Surg 2008; 2: 30.
12. Gupta H, Araki Y, Davidoff AM, et al. Evaluation of pediatric oncology patients with previous multiple central catheters for vascular access: is Doppler ultrasound needed? Pediatr Blood Cancer 2007; 48: 527-31.
13. Babu R, Spicer RD. Implanted vascular access devices (ports) in children: complications and their prevention. Pediatr Surg Int 2002; 18: 50-3.
14. Seiler CM, Frohlich BE, Dorsam UL, Kienle P, Buchler MW, Knaebel HP. Surgical technique for totally implantable access ports (TIAP) needs improvement: a multivariate analysis of 400 patients. J Surg Oncol 2006; 93: 24-9.
15. Sotir MJ, Lewis C, Bisher EW, Ray SM, Soucie JM, Blumberg HM. Epidemiology of device-associated infections related to a long-term implantable vascular access device. Infect Control Hosp Epidemiol 1999; 20: 187-91.
16. Vandoni RE, Guerra A, Sanna P, Bogen M, Cavalli F, Gertsch P. Randomised comparison of complications from three different permanent central venous access systems. Swiss Med Wkly 2009;139: 313-6.